---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-030652"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:34:32.874857+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech grants 136,000 stock options to CEO, CFO, and President at $3.71

## Summary
- Pardeep Nijhawan (CEO) granted 49,000 options; monthly vesting over 36 months, 10-year term.
- Kathi Niffenegger (CFO) granted 43,500 options; Michael Brooks (President) also granted 43,500 options.
- Exercise price set at $3.71 per share, equal to closing price on grant date (Feb 28, 2022).
- Options vest monthly over 36 months; no immediate change in executive compensation.

## SEC filing metadata
- accession: 0001104659-22-030652
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000110465922030652/0001104659-22-030652-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000110465922030652/tm228418d3_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-030652
- JSON: https://secwatch.observer/filing/0001104659-22-030652.json
- Plain text: https://secwatch.observer/filing/0001104659-22-030652.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.